FIUME, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 2.329
AS - Asia 1.585
EU - Europa 1.453
AF - Africa 133
SA - Sud America 72
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.579
Nazione #
US - Stati Uniti d'America 2.310
CN - Cina 479
VN - Vietnam 403
SG - Singapore 394
GB - Regno Unito 381
IT - Italia 239
DE - Germania 148
SE - Svezia 144
UA - Ucraina 125
IN - India 89
FR - Francia 85
HK - Hong Kong 79
RU - Federazione Russa 72
CH - Svizzera 57
TG - Togo 56
BR - Brasile 54
IE - Irlanda 46
JP - Giappone 33
ZA - Sudafrica 30
FI - Finlandia 28
EE - Estonia 25
NL - Olanda 20
BG - Bulgaria 19
BE - Belgio 18
KR - Corea 18
BD - Bangladesh 17
CI - Costa d'Avorio 16
PH - Filippine 14
SC - Seychelles 13
NG - Nigeria 11
IQ - Iraq 10
HR - Croazia 9
TH - Thailandia 9
AR - Argentina 8
CA - Canada 8
PL - Polonia 8
GR - Grecia 6
JO - Giordania 6
SA - Arabia Saudita 6
AT - Austria 5
ID - Indonesia 5
MX - Messico 5
AU - Australia 4
ES - Italia 4
RO - Romania 4
TW - Taiwan 4
EC - Ecuador 3
IL - Israele 3
LT - Lituania 3
TR - Turchia 3
CO - Colombia 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BT - Bhutan 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
HN - Honduras 1
KE - Kenya 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.579
Città #
Southend 317
Ashburn 282
Singapore 263
Fairfield 240
Chandler 208
Woodbridge 141
Wilmington 128
Houston 111
Seattle 109
Ann Arbor 106
Santa Clara 96
San Jose 93
Jacksonville 81
Ho Chi Minh City 78
Hong Kong 74
Princeton 68
Cambridge 67
Beijing 63
Bern 56
Lomé 56
Bologna 54
Hanoi 50
Hefei 50
Dublin 46
New York 45
Boardman 41
Dong Ket 33
Padova 31
Westminster 30
Tokyo 29
Los Angeles 27
Lauterbourg 26
Helsinki 22
Nanjing 21
Berlin 20
Shenyang 19
Sofia 19
Brussels 18
Turin 18
Abidjan 16
Buffalo 16
Council Bluffs 16
Jinan 16
Saint Petersburg 15
Dallas 14
Nanchang 14
Hangzhou 13
Mülheim 13
Haiphong 12
Mahé 12
Seoul 12
Cesenatico 11
Changsha 11
Da Nang 11
Abeokuta 10
Guangzhou 10
Milan 10
San Diego 10
Shanghai 10
Falls Church 9
Zhengzhou 9
Falkenstein 8
Jiaxing 8
Redondo Beach 8
Redwood City 8
São Paulo 8
Tianjin 8
Tân Tiến 8
Baghdad 7
Hebei 7
Wuhan 7
Bengaluru 6
Frankfurt am Main 6
Haikou 6
London 6
Phoenix 6
Redmond 6
The Dalles 6
Verona 6
Yubileyny 6
Amman 5
Can Tho 5
Chicago 5
Dearborn 5
Düsseldorf 5
Nuremberg 5
Olalla 5
Sant'agata De' Goti 5
Turku 5
Warsaw 5
Bangkok 4
Cape Town 4
Castel Maggiore 4
Chennai 4
Des Moines 4
Kunming 4
Medford 4
Pianoro 4
Quận Bình Thạnh 4
Rijeka 4
Totale 3.727
Nome #
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. 242
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 238
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 224
Uso di coniugati della doxorubicina con albumina lattosaminata 220
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 217
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 217
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 211
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 205
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 201
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 200
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin 199
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 196
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 195
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 194
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 190
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 185
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 184
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 182
Procedura per la preparazione di coniugati della doxorubicina con l’albumina umana lattosaminata 170
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 170
Albumin-drug conjugates in the treatment of hepatic disorders. 170
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 167
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 164
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin 153
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis 153
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. 143
Use of conjugates of doxorubicin with lactosaminated albumin. 142
Lactosaminated human albumin: a hepatotropic carrier of drugs. 133
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 119
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 110
null 78
null 71
Totale 5.643
Categoria #
all - tutte 14.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 0 111
2021/2022634 77 14 51 55 52 29 29 36 23 45 128 95
2022/2023753 81 143 33 89 52 58 14 33 108 10 38 94
2023/2024204 12 31 22 23 6 68 7 11 2 11 3 8
2024/2025606 30 68 47 69 131 42 43 28 7 33 10 98
2025/20261.489 124 142 125 133 160 97 101 26 355 139 39 48
Totale 5.643